Zoledronic Acid for Treatment of Osteopenia and Osteoporosis in Women with Primary Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy

BACKGROUND: Postmenopausal women with osteoporosis/osteopenia are at increased risk of fracture. Aromatase inhibitors further increase bone loss in these patients. This study evaluates whether zoledronic acid prevents the bone loss expected when these patients initiate letrozole. PATIENTS AND METHOD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hines, Stephanie L., Sloan, Jeff A., Atherton, Pamela J., Perez, Edith A., Dakhil, Shaker R., Johnson, David B., Reddy, Pavan S., Dalton, Robert J., Mattar, Bassam I., Loprinzi, Charles L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2854212/
https://ncbi.nlm.nih.gov/pubmed/20079640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2009.12.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados